Acura Pharmaceuticals Announces Return of Product Rights from Pfizer By: Benzinga via Benzinga April 10, 2014 at 06:30 AM EDT Acura Pharmaceuticals (NASDAQ: ACUR) announced today a letter agreement with Pfizer Inc. providing for the termination of Pfizer's ... Read More >> Related Stocks: Pfizer